Search research articles
Contact Us
Filters
Showing results (41-50 of 63) with videos related to
Page
of 7
Sort By:
Open Forum Infectious Diseases
|
October 16, 2024
Outcomes of Haploidentical Stem Cell Transplant Recipients With HHV-6B Reactivation
Guy Handley, Amanda Yepes, Eva Eliassen, et al.
Journal of Hematology & Oncology
|
June 6, 2024
Impact of extramedullary multiple myeloma on outcomes with idecabtagene vicleucel
Saurabh Zanwar, Surbhi Sidana, Leyla Shune, et al.
Blood
|
April 8, 2025
Standard-of-Care Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: A CIBMTR Analysis
Surbhi Sidana, Nausheen Ahmed, Othman Salim Akhtar, et al.
Blood
|
September 22, 2025
Target antigen and plasma cell phenotype are critical factors for sensitivity to response-adapted daratumumab therapy
Mark B Meads, Xiaohong Zhao, David R Noyes, et al.
Blood
|
July 8, 2026
Rapid Peak Cilta-cel Expansion is Associated with Delayed Neurotoxicity in Multiple Myeloma
Hitomi Hosoya, Arash Velayati, Danai Dima, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 22, 2023
Relapse timing is associated with distinct evolutionary dynamics in DLBCL
Laura K Hilton, Henry S Ngu, Brett Collinge, et al.
Transplantation and Cellular Therapy
|
June 18, 2026
Exercise Prehabilitation for Older Adults Undergoing CAR-T: Feasibility, Acceptability, and Preliminary Outcomes
Nathan H Parker, Jongphil Kim, Morgan Bean, et al.
Blood Cancer Journal
|
April 12, 2024
Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium
Aimaz Afrough, Hamza Hashmi, Doris K Hansen, et al.
Blood
|
December 9, 2024
Tumor burden quantified by soluble B-cell maturation antigen and metabolic tumor volume determines myeloma CAR-T outcomes
Ciara L Freeman, Jerald Noble, Meghan Menges, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 15, 2023
Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell Lymphoma
Laura K Hilton, Henry S Ngu, Brett Collinge, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 63) with videos related to
Sort By:
Page
of 7
Open Forum Infectious Diseases
|
October 16, 2024
Outcomes of Haploidentical Stem Cell Transplant Recipients With HHV-6B Reactivation
Guy Handley, Amanda Yepes, Eva Eliassen, et al.
Journal of Hematology & Oncology
|
June 6, 2024
Impact of extramedullary multiple myeloma on outcomes with idecabtagene vicleucel
Saurabh Zanwar, Surbhi Sidana, Leyla Shune, et al.
Blood
|
April 8, 2025
Standard-of-Care Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: A CIBMTR Analysis
Surbhi Sidana, Nausheen Ahmed, Othman Salim Akhtar, et al.
Blood
|
September 22, 2025
Target antigen and plasma cell phenotype are critical factors for sensitivity to response-adapted daratumumab therapy
Mark B Meads, Xiaohong Zhao, David R Noyes, et al.
Blood
|
July 8, 2026
Rapid Peak Cilta-cel Expansion is Associated with Delayed Neurotoxicity in Multiple Myeloma
Hitomi Hosoya, Arash Velayati, Danai Dima, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 22, 2023
Relapse timing is associated with distinct evolutionary dynamics in DLBCL
Laura K Hilton, Henry S Ngu, Brett Collinge, et al.
Transplantation and Cellular Therapy
|
June 18, 2026
Exercise Prehabilitation for Older Adults Undergoing CAR-T: Feasibility, Acceptability, and Preliminary Outcomes
Nathan H Parker, Jongphil Kim, Morgan Bean, et al.
Blood Cancer Journal
|
April 12, 2024
Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium
Aimaz Afrough, Hamza Hashmi, Doris K Hansen, et al.
Blood
|
December 9, 2024
Tumor burden quantified by soluble B-cell maturation antigen and metabolic tumor volume determines myeloma CAR-T outcomes
Ciara L Freeman, Jerald Noble, Meghan Menges, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 15, 2023
Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell Lymphoma
Laura K Hilton, Henry S Ngu, Brett Collinge, et al.
Page
of 7